Identification and Screening of Bioactive Phytocompounds against Matrix Metalloproteinase-9, Targeting Cancer Cell Proliferation and Angiogenesis Phytocompounds Targeting MMP-9 in Cancer
Iranian Journal of Pharmaceutical Sciences,
Vol. 21 No. 1 (2025),
21 January 2025
,
Page 323-343
https://doi.org/10.22037/ijps.v21i1.48139
Abstract
Matrix metalloproteinase-9 (MMP-9) is a zinc-dependent endopeptidase that plays a key role in tumor progression, metastasis, and angiogenesis by degrading extracellular matrix components and modulating cell signaling pathways. Due to its overexpression in various cancers and contribution to tumor microenvironment remodeling, MMP-9 is a critical therapeutic target for cancer therapy. This study employed a comprehensive computational strategy to identify natural MMP-9 inhibitors from phytochemical databases. Different bioinformatics methods, such as molecular docking, ADME/T profiling, PASS analysis, pIC50 analysis, drug-likeness prediction, and molecular dynamic (MD) simulation, were carried out. Molecular docking analysis revealed strong binding affinities for Naringenin (-9.5 kcal/mol) and Rhamnetin (-8.9 kcal/mol), which formed stable interactions with MMP-9's catalytic domain. PASS analysis further validated their inhibitory potential (Naringenin: Pa = 0.764; Rhamnetin: Pa = 0.755). Crucially, both compounds exhibited exceptional ADME/T properties, such as high oral bioavailability, optimal metabolic stability, and low toxicity risks, which are essential for preclinical drug development. The molecular dynamics simulations confirmed their binding stability, with favorable hydrogen bonding patterns and minimal structural fluctuations. Other promising candidates like Epigallocatechin-gallate, Naringenin, and Rhamnetin emerged as beautiful leads due to their dual advantages of potent MMP-9 inhibition and drug-like pharmacokinetic profiles. The findings support advancing these phytochemicals into experimental studies as potential anti-cancer agents targeting MMP-9-mediated pathological processes in cancer development.
- ADME/T
- MMP-9
- Molecular docking
- MD simulation
- Phytochemicals
- Tumor
How to Cite
References
Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis (2010) 31(1):100-10.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144(5):646-74.
Bhat AS, Ahmed M, Abbas K, Mustafa M, Alam M, Salem MA, et al. Cancer initiation and progression: a comprehensive review of carcinogenic substances, anti-cancer therapies, and regulatory frameworks. Asian J Res Biochem (2024) 14(4):111-25.
Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog (2013) 18(1-2):43-73.
Mustafa M, Abbas K, Alam M, Habib S, Zulfareen, Hasan GM, et al. Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer. Front Oncol (2024) 14:1427802.
Yue B. Biology of the extracellular matrix: an overview. J Glaucoma (2014) 23(8 Suppl 1):S20-3.
Dzobo K, Dandara C. The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis. Biomimetics (Basel) (2023) 8(2).
Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol (2014) 15(12):786-801.
Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell (2010) 141(1):52-67.
Niland S, Riscanevo AX, Eble JA. Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression. Int J Mol Sci (2021) 23(1).
Laronha H, Caldeira J. Structure and Function of Human Matrix Metalloproteinases. Cells (2020) 9(5).
Gonzalez-Avila G, Sommer B, Mendoza-Posada DA, Ramos C, Garcia-Hernandez AA, Falfan-Valencia R. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer. Crit Rev Oncol Hematol (2019) 137:57-83.
Sabeh F, Shimizu-Hirota R, Weiss SJ. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol (2009) 185(1):11-9.
Augoff K, Hryniewicz-Jankowska A, Tabola R, Stach K. MMP9: A Tough Target for Targeted Therapy for Cancer. Cancers (Basel) (2022) 14(7).
Barillari G. The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process. Int J Mol Sci (2020) 21(12).
Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol (2007) 8(3):221-33.
Deryugina EI, Kiosses WB. Intratumoral Cancer Cell Intravasation Can Occur Independent of Invasion into the Adjacent Stroma. Cell Rep (2017) 19(3):601-16.
Deryugina EI, Quigley JP. Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol (2015) 44-46:94-112.
Parham S, Kharazi AZ, Bakhsheshi-Rad HR, Nur H, Ismail AF, Sharif S, et al. Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials. Antioxidants (Basel) (2020) 9(12).
Ansari MS, Abbas K, Alam M, Usmani N, Khan A, Khan AA, et al. Investigating the anxiolytic potential of Withania somnifera: a GC–MS and in silico Study targeting MAO-A inhibition. Discover Plants (2025) 2(1):89.
Alam M, Abbas K, Raza MT, Abedi SMH, Haq H, Mustafa M. Identification of Aquaporin 3 Inhibitors from Santalum album Phytochemicals for Melanoma treatment: A Computational Study: Targeting Aquaporin 3: Santalum Album in Melanoma Therapy. Iranian Journal of Pharmaceutical Sciences (2024) 20(4):293- 314.
Alonso-Castro AJ, Villarreal ML, Salazar-Olivo LA, Gomez-Sanchez M, Dominguez F, Garcia-Carranca A. Mexican medicinal plants used for cancer treatment: pharmacological, phytochemical and ethnobotanical studies. J Ethnopharmacol (2011) 133(3):945-72.
Berdigaliyev N, Aljofan M. An overview of drug discovery and development. Future Med Chem (2020) 12(10):939-47.
Alam M, Abbas K, Ahmad A, Showkat N, Sen R. Identification of Hsp90 inhibitors from Ananas comosus potential phytochemicals for lung cancer treatment. The Journal of Phytopharmacology (2024) 13:12-9.
Tilaoui M, Ait Mouse H, Zyad A. Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids. Front Pharmacol (2021) 12:719694.
Raina H, Soni G, Jauhari N, Sharma N, Bharadvaja N. Phytochemical importance of medicinal plants as potential sources of anti-cancer agents. Turkish Journal of Botany (2014) 38(6):1027-35.
Deep A, Kumar D, Bansal N, Narasimhan B, Marwaha RK, Sharma PC. Understanding mechanistic aspects and therapeutic potential of natural substances as anti-cancer agents. Phytomedicine Plus (2023) 3(2):100418.
Akter R, Uddin SJ, Grice ID, Tiralongo E. Cytotoxic activity screening of Bangladeshi medicinal plant extracts. J Nat Med (2014) 68(1):246-52.
Solowey E, Lichtenstein M, Sallon S, Paavilainen H, Solowey E, Lorberboum-Galski H. Evaluating medicinal plants for anti-cancer activity. ScientificWorldJournal (2014) 2014:721402.
Brassart-Pasco S, Brézillon S, Brassart B, Ramont L, Oudart JB, Monboisse JC. Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression. Front Oncol (2020) 10:397.
Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes. Mol Cancer Ther (2018) 17(6):1147-55.
Mir SA, Dar A, Hamid L, Nisar N, Malik JA, Ali T, et al. Flavonoids as promising molecules in the cancer therapy: An insight. Current Research in Pharmacology and Drug Discovery (2024) 6:100167.
Ponte LGS, Pavan ICB, Mancini MCS, da Silva LGS, Morelli AP, Severino MB, et al. The Hallmarks of Flavonoids in Cancer. Molecules (2021) 26(7).
Zhang C, Kim SK. Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects. Mar Drugs (2009) 7(2):71-84.
Lans C, van Asseldonk T. Dr. Duke’s Phytochemical and Ethnobotanical Databases, a Cornerstone in the Validation of Ethnoveterinary Medicinal Plants, as Demonstrated by Data on Pets in British Columbia. In: Máthé Á, editor. Medicinal and Aromatic Plants of North America. Cham: Springer International Publishing; 2020. p. 219-46.
Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem Substance and Compound databases. Nucleic Acids Res (2016) 44(D1):D1202-13.
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. Journal of computational chemistry (2004) 25(13):1605-12.
Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput (2015) 11(8):3696-713.
Abbas K, Alam M, Ansari MS, Khan A, Raza MT, Khan Z, et al. Isorauhimbine and Vinburnine as Novel 5-HT2A Receptor Antagonists From Rauwolfia serpentina for the Treatment of Insomnia: An In Silico Investigation. (2024).
Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. Journal of Chemical Information and Modeling (2021) 61(8):3891-8.
Pawar RP, Rohane SH. Role of autodock vina in PyRx molecular docking. (2021).
Yoshikawa N, Hutchison GR. Fast, efficient fragment-based coordinate generation for Open Babel. Journal of Cheminformatics (2019) 11(1):49.
Druzhilovskiy DS, Rudik AV, Filimonov DA, Gloriozova TA, Lagunin AA, Dmitriev AV, et al. Computational platform Way2Drug: from the prediction of biological activity to drug repurposing. Russian Chemical Bulletin (2017) 66(10):1832-41.
Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, et al. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Research (2024) 52(W1):W422-W31.
Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies (2004) 1(4):337-41.
Kufareva I, Lenoir M, Dancea F, Sridhar P, Raush E, Bissig C, et al. Discovery of novel membrane binding structures and functions. Biochem Cell Biol (2014) 92(6):555-63.
Yin X, Wang X, Li Y, Wang J, Wang Y, Deng Y, et al. CODD-Pred: A Web Server for Efficient Target Identification and Bioactivity Prediction of Small Molecules. Journal of Chemical Information and Modeling (2023) 63(20):6169-76.
Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res (2018) 46(W1):W257-w63.
Yadav P, Azram M, Faraz M, Alam M, Khan S. In Silico Screening of Rauwolfia Serpentina Phytochemicals as Orexin Receptor-2 Agonists for the Management of Narcolepsy.
Tumskiy RS, Tumskaia AV. Multistep rational molecular design and combined docking for discovery of novel classes of inhibitors of SARS-CoV-2 main protease 3CLpro. Chem Phys Lett (2021) 780:138894.
Ghahremanian S, Rashidi MM, Raeisi K, Toghraie D. Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. J Mol Liq (2022) 354:118901.
Ching KWC, Nazri MNM, Rachman ARA, Mustafa KMF, Mokhtar NF. In silico Study of shape complementarity, binding affinity, and protein–ligand interactions of systematic evolution of ligands by exponential enrichment-aptamer to programmed death ligand-1 using patchdock. Journal of Preventive, Diagnostic and Treatment Strategies in Medicine (2022) 1(2):127-33.
Yin X, Wang X, Li Y, Wang J, Wang Y, Deng Y, et al. CODD-Pred: A Web Server for Efficient Target Identification and Bioactivity Prediction of Small Molecules. J Chem Inf Model (2023) 63(20):6169-76.
Saragusti AC, Ortega MG, Cabrera JL, Estrin DA, Marti MA, Chiabrando GA. Inhibitory effect of quercetin on matrix metalloproteinase 9 activity Molecular mechanism and structure–activity relationship of the flavonoid–enzyme interaction. European Journal of Pharmacology (2010) 644(1):138-45.
Yarmohammadi E, Naimiyan A, Taherkhani A. Flavonoids as dual-action agents for anti-cancer and anti-tooth caries: a molecular docking and dynamics simulation on MMP2 inhibition. IJS Oncology (2024) 9(2):25-33.
Zhou Z-G, Yao Q-Z, Lei D, Zhang Q-Q, Zhang J. Investigations on the mechanisms of interactions between matrix metalloproteinase 9 and its flavonoid inhibitors using a combination of molecular docking, hybrid quantum mechanical/molecular mechanical calculations, and molecular dynamics simulations. Canadian Journal of Chemistry (2014) 92:821-30.
Rahman L, Talha Khalil A, Ahsan Shahid S, Shinwari ZK, Almarhoon ZM, Alalmaie A, et al. Diosmin: A promising phytochemical for functional foods, nutraceuticals and cancer therapy. Food Sci Nutr (2024) 12(9):6070-92.
Tanabe H, Suzuki T, Ohishi T, Isemura M, Nakamura Y, Unno K. Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anti-cancer Activity. Molecules (2023) 28(2):525.
Du GJ, Zhang Z, Wen XD, Yu C, Calway T, Yuan CS, et al. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients (2012) 4(11):1679-91.
Hermawan A, Ikawati M, Jenie RI, Khumaira A, Putri H, Nurhayati IP, et al. Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies. Saudi Pharm J (2021) 29(1):12-26.
Lan L, Wang Y, Pan Z, Wang B, Yue Z, Jiang Z, et al. Rhamnetin induces apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway. Oncol Lett (2019) 17(1):676-82.
Wang S, Li Z, Liu W, Wei G, Yu N, Ji G. Neohesperidin Induces Cell Cycle Arrest, Apoptosis, and Autophagy via the ROS/JNK Signaling Pathway in Human Osteosarcoma Cells. The American Journal of Chinese Medicine (2021) 49(05):1251-74.
- Abstract Viewed: 435 times
- IJPS_Volume21_Issue1_Pages323-343 Downloaded: 251 times